FDA warning letter
Closeout letter
Issue date
20 Feb 2019
Issuing office
Dallas District Office
Posted date
26 Feb 2019
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Issue date
19 Nov 2019
Pure Source
Warning letter
Headquarters
United States of America